ANI Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2008 | — | — | $11.8M |
| Dec 2009 | — | — | $29.9M |
| Jun 2010 | — | — | $46.4M |
| Sep 2010 | — | — | $35.5M |
| Dec 2010 | $25.6M | $44.8M | $38.2M |
| Mar 2011 | — | — | $51.3M |
| Jun 2011 | $31.2M | $42.8M | $37.1M |
| Sep 2011 | $30.7M | $74.9M | $69.6M |
| Dec 2011 | $24.6M | $62.4M | $0 |
| Mar 2012 | $16.6M | $54.6M | $49.5M |
| Jun 2012 | $16.4M | $47.3M | $119.6K |
| Sep 2012 | $10.9M | $43.2M | $148.3K |
| Dec 2012 | $10.6M | $13.7M | $11.0K |
| Mar 2013 | $9.3M | $35.4M | $41.0K |
| Jun 2013 | $6.2M | $41.7M | $12.6M |
| Sep 2013 | $6.6M | $43.3M | $10.9M |
| Dec 2013 | $3.5M | $44.5M | $11.1M |
| Mar 2014 | $4.6M | $96.7M | $51.4M |
| Jun 2014 | $3.8M | $95.4M | $53.0M |
| Sep 2014 | $8.1M | $107.6M | $35.1M |
| Dec 2014 | $119.8M | $259.6M | $169.0M |
| Mar 2015 | $121.2M | $266.0M | $165.6M |
| Jun 2015 | $120.6M | $270.1M | $166.7M |
| Sep 2015 | $127.4M | $283.3M | $150.9M |
| Dec 2015 | $125.2M | $285.3M | $154.7M |
| Mar 2016 | $131.4M | $291.6M | $77.7M |
| Jun 2016 | $144.2M | $308.0M | $15.0M |
| Sep 2016 | $150.5M | $319.4M | $16.2M |
| Dec 2016 | $153.2M | $322.9M | $27.4M |
| Mar 2017 | $184.9M | $357.1M | $10.8M |
| Jun 2017 | $182.7M | $359.2M | $8.4M |
| Sep 2017 | $187.7M | $370.5M | $18.0M |
| Dec 2017 | $237.4M | $412.1M | $31.1M |
| Mar 2018 | $238.4M | $418.0M | $52.0M |
| Jun 2018 | $239.1M | $424.2M | $55.0M |
| Sep 2018 | $247.0M | $439.4M | $44.1M |
| Dec 2018 | $233.3M | $430.6M | $43.0M |
| Mar 2019 | $234.7M | $434.4M | $38.2M |
| Jun 2019 | $239.3M | $446.9M | $40.6M |
| Sep 2019 | $243.6M | $456.8M | $59.7M |
| Dec 2019 | $244.0M | $456.8M | $62.3M |
| Mar 2020 | $281.1M | $482.2M | $20.4M |
| Jun 2020 | $274.0M | $465.4M | $27.7M |
| Sep 2020 | $267.5M | $462.6M | $17.9M |
| Dec 2020 | $265.5M | $461.2M | $7.9M |
| Mar 2021 | $260.1M | $463.8M | $25.1M |
| Jun 2021 | $288.2M | $480.2M | $24.3M |
| Sep 2021 | $279.1M | $470.5M | $15.3M |
| Dec 2021 | $412.9M | $771.6M | $100.3M |
| Mar 2022 | $398.8M | $744.8M | $76.9M |
| Jun 2022 | $414.4M | $751.3M | $63.4M |
| Sep 2022 | $402.4M | $739.1M | $56.3M |
| Dec 2022 | $421.5M | $760.1M | $48.2M |
| Mar 2023 | $425.7M | $765.2M | $67.8M |
| Jun 2023 | $424.9M | $859.3M | $161.7M |
| Sep 2023 | $435.2M | $889.9M | $193.1M |
| Dec 2023 | $446.8M | $904.4M | $221.1M |
| Mar 2024 | $437.7M | $914.5M | $228.6M |
| Jun 2024 | $440.1M | $920.8M | $240.1M |
| Sep 2024 | $856.6M | $1.29B | $145.0M |
| Dec 2024 | $855.9M | $1.28B | $144.9M |
| Mar 2025 | $849.0M | $1.29B | $149.8M |
| Jun 2025 | $881.4M | $1.34B | $217.8M |
| Sep 2025 | $902.3M | $1.41B | $262.6M |
| Dec 2025 | $899.7M | $1.44B | $285.6M |
| Mar 2026 | $859.7M | $1.42B | $311.2M |
| Jun 2026 | $896.9M | $1.49B | $360.2M |